Dorzolamide Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

36 API Suppliers, 14 USDMF, 13 CEP/COS, 4 JDMF, 8 EU WC, 12 KDMF, 15 NDC API, 25 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

9 Suppliers

9 Suppliers

DOSSIERs // Finished Dosage Formulations

161 Dossiers, 35 FDA Orange Book, 85 Europe, 17 Canada, 6 Australia, 5 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 12 SPI Pharma, 4 Actylis, 3 Roquette, 2 Microlex e.U, 2 Kerry, 2 Gangwal Healthcare, 2 Gangwal Chemicals, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Rochem International Inc, 1 Sigachi Industries, 1 Ingredion Pharma Solutions, 1 Pfanstiehl, 1 DKSH, 1 BASF, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Finar

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 10 Direct Compression, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 4 Co-Processed Excipients, 4 Parenteral, 3 Disintegrants & Superdisintegrants, 3 Granulation, 2 Solubilizers, 2 Controlled & Modified Release, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

GLOBAL SALES INFORMATION

42 US Medicaid Prescriptions, 65 Finished Drug Prices

MARKET PLACE

14 APIs, 1 DOSSIERS // FDF

PATENTS

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 4 USP Standards, 4 JP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

16 News

16 News

List of Suppliers

Full Screen View

Reset Filter

Price Info

Bhavna Laboratories

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

India

Virtual Booth

Digital Content

N-((4S,6S)-6-Methyl-7,7-dioxido-2-sulfamoyl-5,6-dihydro...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

147200-03-1

End Use API

Dorzolamide Hydrochloride

About The Company

Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian company that specializes in manufacturing AP...

Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian company that specializes in manufacturing APIs and intermediates. Besides being approved by the FDA of India, Bhavna has obtained cGMP certificates for all the drugs it manufactures. It also conforms to WHO GMP standards. With a focus on muscle relaxants and ophthalmic products, Bhavna provides custom manufacturing services for APIs and intermediates. Bhavna’s facility near Mumbai, India, adheres to cGMP regulations and has a yearly production capacity of over 500 tonnes. Bhavna Laboratories exports its products to various countries in Southeast Asia, the Middle East, and Europe.